X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (94) 94
index medicus (92) 92
oncology (91) 91
male (85) 85
prostate cancer (62) 62
aged (36) 36
middle aged (36) 36
prostatic neoplasms - drug therapy (33) 33
prostatic neoplasms - pathology (33) 33
cancer (32) 32
urology & nephrology (26) 26
metastasis (25) 25
abiraterone acetate (23) 23
aged, 80 and over (22) 22
antineoplastic agents - therapeutic use (22) 22
treatment outcome (22) 22
adult (21) 21
prostatic neoplasms, castration-resistant - drug therapy (21) 21
docetaxel (20) 20
article (19) 19
survival (19) 19
androgen receptor (18) 18
enzalutamide (18) 18
prostate (18) 18
abiraterone (17) 17
androstenes (17) 17
research (17) 17
antitumor-activity (16) 16
castration (16) 16
expression (16) 16
prostate-specific antigen - blood (16) 16
prostatic neoplasms - genetics (16) 16
prostatic neoplasms, castration-resistant - pathology (16) 16
chemotherapy (15) 15
care and treatment (14) 14
metastases (14) 14
mutation (14) 14
androgens (13) 13
androstenols - therapeutic use (13) 13
phenylthiohydantoin - analogs & derivatives (13) 13
prostatic neoplasms - metabolism (13) 13
steroid 17-alpha-hydroxylase - antagonists & inhibitors (13) 13
tumors (13) 13
urology (13) 13
castration-resistant prostate cancer (12) 12
clinical trials (12) 12
disease progression (12) 12
medical research (12) 12
neoplasm metastasis (12) 12
patients (12) 12
prognosis (12) 12
receptors, androgen - genetics (12) 12
animals (11) 11
biomarkers (11) 11
cell biology (11) 11
disease-free survival (11) 11
receptors, androgen - metabolism (11) 11
androgen antagonists - therapeutic use (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
cancer therapies (10) 10
cells (10) 10
circulating tumor-cells (10) 10
orchiectomy (10) 10
prostatic neoplasms - surgery (10) 10
survival analysis (10) 10
therapy (10) 10
analysis (9) 9
cyp17 (9) 9
genetic aspects (9) 9
i clinical-trial (9) 9
increased survival (9) 9
men (9) 9
neoplastic cells, circulating - pathology (9) 9
prednisone (9) 9
progression (9) 9
prostatic neoplasms, castration-resistant - blood (9) 9
prostatic neoplasms, castration-resistant - genetics (9) 9
prostatic neoplasms, castration-resistant - metabolism (9) 9
abridged index medicus (8) 8
antiandrogen withdrawal (8) 8
breast-cancer (8) 8
clinical-trials (8) 8
deoxyribonucleic acid--dna (8) 8
kaplan-meier estimate (8) 8
pathology (8) 8
prostatic neoplasms - blood (8) 8
resistant prostate-cancer (8) 8
steroidal inhibitors (8) 8
trans-activators - genetics (8) 8
transcriptional regulator erg (8) 8
antiandrogen (7) 7
antineoplastic agents - pharmacology (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
biomarkers, tumor - analysis (7) 7
carcinoma (7) 7
diagnosis (7) 7
drug resistance, neoplasm (7) 7
erg (7) 7
female (7) 7
health aspects (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 387, Issue 10024, pp. 1163 - 1177
Summary Background Long-term hormone therapy has been the standard of care for advanced prostate cancer since the 1940s. STAMPEDE is a randomised controlled... 
Internal Medicine | ANDROGEN-DEPRIVATION THERAPY | MEDICINE, GENERAL & INTERNAL | PREDNISONE | DESIGN | MITOXANTRONE | CABAZITAXEL | CLINICAL-TRIALS | OPEN-LABEL | CHEMOTHERAPY | ENZALUTAMIDE | ESTRAMUSTINE | Survival analysis | Medical prognosis | Clinical trials | Hormone replacement therapy | Metastasis | Prostate cancer | Cancer therapies | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2015, Volume 373, Issue 18, pp. 1697 - 1708
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2017, Volume 377, Issue 4, pp. 338 - 351
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2009, Volume 27, Issue 23, pp. 3742 - 3748
Purpose It has been postulated that castration-resistant prostate cancer (CRPC) commonly remains hormone dependent. Abiraterone acetate is a potent, selective,... 
LEUKEMIA GROUP-B | II CLINICAL-TRIALS | WORKING GROUP | ANTIANDROGEN WITHDRAWAL | ANDROGEN BIOSYNTHESIS | ONCOLOGY | STEROIDAL INHIBITORS | PHASE-II | END-POINTS | DOSE KETOCONAZOLE | HORMONAL-THERAPY | Steroid 17-alpha-Hydroxylase - antagonists & inhibitors | Prospective Studies | Humans | Middle Aged | Drug Resistance, Neoplasm | Male | Neoplasms, Hormone-Dependent - immunology | Androstenols - therapeutic use | Prostatic Neoplasms - immunology | Enzyme Inhibitors - administration & dosage | Antineoplastic Agents, Hormonal - therapeutic use | Aged, 80 and over | Testosterone - blood | Prostatic Neoplasms - drug therapy | Prostatic Neoplasms - pathology | Antineoplastic Agents, Hormonal - pharmacology | Drug Administration Schedule | Androstenols - pharmacology | Antineoplastic Agents, Hormonal - administration & dosage | Enzyme Inhibitors - pharmacology | Kaplan-Meier Estimate | Androgen Antagonists - pharmacology | Androstenes | Enzyme Inhibitors - therapeutic use | Disease Progression | Prostate-Specific Antigen - blood | Neoplasms, Hormone-Dependent - pathology | Androgen Antagonists - therapeutic use | Aged | Androstenols - administration & dosage | Androgen Antagonists - administration & dosage | Neoplasms, Hormone-Dependent - drug therapy | Adrenal Cortex Hormones - administration & dosage | Index Medicus
Journal Article
Journal Article
Nature Reviews Urology, ISSN 1759-4812, 06/2015, Volume 12, Issue 6, pp. 312 - 313
Journal Article
The Lancet, ISSN 0140-6736, 12/2018, Volume 392, Issue 10162, pp. 2353 - 2366
Journal Article
Journal Article
The Lancet Oncology, ISSN 1470-2045, 04/2019, Volume 20, Issue 4, pp. 556 - 569
In the PROSPER trial, enzalutamide significantly improved metastasis-free survival in patients with non-metastatic, castration-resistant prostate cancer. Here,... 
EXPLORATORY ANALYSES | MANAGEMENT | THERAPY | ONCOLOGY | PREFERENCES | PERSPECTIVES | QUALITY-OF-LIFE | METASTASIS-FREE SURVIVAL | CLINICAL-OUTCOMES | MMRM | Clinical trials | Medicine, Experimental | Medical research | Metastasis | Prostate cancer | Patient outcomes
Journal Article